assessing biosimilarity based on ion signal statistics in lc/ms peptide maps
Published 10 years ago • 451 plays • Length 7:26Download video MP4
Download video MP3
Similar videos
-
29:38
making lc-ms smarter for biopharmaceutical characterization and monitoring
-
21:06
contrasting lbas and lc-ms for peptide and protein bioanalysis
-
18:36
introduction to peptides and proteins for bioanalysis using lc-ms
-
4:06
charge variant analysis with lc-ms | biopharma spotlight | episode 4 of 7
-
49:56
broade: fundamentals of peptide and protein mass spectrometry
-
1:01:54
acs｜mastering hplc method development: what are all those buttons for?
-
4:42
quickly understand liquid chromatography mass spectrometry (lc-ms simply explained)
-
7:54
using mass detection in biopharm laboratories: peptides
-
45:02
webinar | part 1 of 3 | transforming high performance lc-ms analysis in biopharma
-
5:48
using uplc for hplc-based large molecule applications: transferring legacy peptide maps
-
45:01
sensitivity, selectivity, and speed | solving analytical challenges in endocrinology using lc-ms/ms
-
1:57
application spotlight: peptide mapping with acquity premier solution
-
9:59
peptide mapping | bioaccord system demo | 4 of 5
-
6:32
a quick look at how we help ensure that pcr diagnostics work for virus detection
-
3:15
peptide mapping reproducibility | biopharma spotlight | episode 6 of 7
-
19:59
lc-ms/ms for bioanalytical peptide and protein quantification: ms considerations
-
7:58
using mass detection in biopharm laboratories
-
17:20
biosimilar comparability (asms 2013)
-
20:41
identification of surrogate peptides for lc-ms protein quantification
-
18:20
ion mobility ms for protein and peptide-based biotherapeutic analysis